This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Kyoto University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kei Taneishi: Innovator in Protein-Compound Interaction Estimation
Introduction
Kei Taneishi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of chemical genomics, particularly in the estimation of protein-compound interactions. His innovative approach combines chemical substance information with biological data to enhance the efficiency of compound screening.
Latest Patents
Taneishi holds a patent titled "Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information." This patent describes a data processing method that estimates compound-protein interactions by utilizing both chemical properties and biological sequence information. The method involves defining two spaces representing chemical substance groups and employing multivariable analysis techniques or machine learning methods to increase the correlation between these spaces.
Career Highlights
Kei Taneishi is affiliated with Kyoto University, where he continues to advance research in chemical genomics. His work has garnered attention for its potential applications in drug discovery and development. With a focus on rational design, Taneishi's contributions are paving the way for more effective screening processes in pharmaceutical research.
Collaborations
Some of Taneishi's notable coworkers include Yasushi Okuno and Gozoh Tsujimoto. Their collaborative efforts enhance the research environment and contribute to the innovative projects at Kyoto University.
Conclusion
Kei Taneishi is a key figure in the field of protein-compound interaction estimation, with a patent that showcases his innovative approach to chemical genomics. His work at Kyoto University continues to influence the landscape of drug discovery and compound screening.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
